Models for institutional and professional accreditation of haemophilia centres in Italy

Haemophilia

Volumn 19, Issue 4, 2013, Pages

  Calizzani, G ^a   Vaglio, S ^a   Arcieri, R ^b   Menichini, I ^b   Tagliaferri, A ^c   Antoncecchi, S ^d   Carloni, M T ^e   Breda, A ^f   Santagostino, E ^g   Ghirardini, A ^h   Tamburrini, M R ^h   Morfini, M ⁱ   Mannucci, P M ^j   Grazzini, G ^a  

^a Italian National Blood Centre   (Italy)

^b Italian Federation of Haemophilia Societies (FedEmo)   (Italy)

^c ARPA Emilia Romagna   (Italy)

^d Apulia Regional Health Agency   (Italy)

^e Dipartimento per le Politiche Integrate di Sicurezza e per la Protezione Civile   (Italy)

^f Pubblich Health Service   (Italy)

^g Directorate General of Health of the Lombardy Region   (Italy)

^h MINISTRY OF HEALTH   (Italy)

ⁱ Italian Association of Haemophilia Centres (AICE)   (Italy)

^j FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

more..

Author keywords

Accreditation; Haemophilia; Haemophilia centres; Recommendations; Requirements; Standards

Indexed keywords

ACCREDITATION; ARTICLE; DRUG BIOAVAILABILITY; HEALTH CARE PERSONNEL; HEMOPHILIA; HOME CARE; HUMAN; ITALY; PLANNING; POLICY; PRIORITY JOURNAL; REGISTER;

ACADEMIES AND INSTITUTES; ACCREDITATION; DELIVERY OF HEALTH CARE; HEALTH PLANNING GUIDELINES; HEMOPHILIA A; HUMANS; ITALY; MODELS, THEORETICAL;

EID: 84879464631     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12141     Document Type: Article

References (21)

1. Stonebraker JS, Bolton-Maggs PHB, Soucie MJ, Walker I, Brooker M. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia 2010; 16: 20-32.
2. Stonebraker JS, Bolton-Maggs PHB, Soucie MJ, Walker I, Brooker M. A study of variations in the reported haemophilia B prevalence around the world. Haemophilia 2012; 18: e91-4.
3. Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med 2004; 351: 683-94.
4. Rabiner SF, Telfer MC. Home transfusion for patients with hemophilia A. N Engl J Med 1970; 283: 1011-5.
5. Mannucci PM, Tuddenham EG. The hemophilias-from royal genes to gene therapy. N Engl J Med 2001; 344: 1773-9.
6. Wood WI, Capon DJ, Simonsen CC et al. Expression of active human factor VIII from recombinant DNA clones. Nature 1984; 312: 330-7.
7. White GC 2nd, Mc Millan CW, Kingdon HS, Shoemaker CB. Use of recombinant antihemophilic factor in the treatment of two patients with classic hemophilia. N Engl J Med 1989; 320: 166-70.
8. Tagliaferri A, Rivolta GF, Iorio A et al. Italian Association of Hemophiliac Centers. Mortality and causes of death in Italian persons with haemophilia, 1990-2007. Haemophilia 2010; 16: 437-46.
9. Siboni SM, Mannucci PM, Gringeri A et al. Italian Association of Haemophilia Centres (AICE). Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009; 7: 780-6.
10. World Federation of Haemophilia. The cornerstone of global development: 45 years of progress. Haemophilia 2008; 14(Suppl 3): 1-9.
11. Scalone L, Mantovani LG, Mannucci PM, Gringeri A. COCIS Study Investigators. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia 2006; 12:154-62.
12. Gringeri A, Muca-Peria M, Mangiafico L, von Mackensen S. Pharmacotherapy of haemophilia A. Expert Opin Biol Ther 2011; 11: 1039-53.
13. Association of Italian Hemophilia Centres Directors. Italian Registry of Haemophilia and Allied Disorders. Available at http://www.aiceonline.it/emocard/summaries.htm. Accessed August 8, 2012.
14. Calizzani G, Lanzoni M, Candura F et al. Analisi della domanda dei principali medicinali plasmaderivati in Italia. Anni 2007-2011. Rome: Istituto Superiore di Sanità 2012. Rapporti Istisan 12/53; 57-69; 139-42. Available at http://www.iss.it/publ/rapp/cont.php?id=2678&lang=1&tipo=5&anno=2012. Accessed March 25, 2013.
15. Alioto A, Garnero A, Calizzani G, Arcieri R. Lo sviluppo dei percorsi per la gestione delle emergenze emorragiche nelle regioni italiane. Blood Transfus 2011; 9(Suppl.6, RE1): s6.
16. Federazione delle Associazioni Emofilici. Il quadro dell'emofilia in Italia: i bisogni delle persone e le strategie messe in campo. Rapporto ICON. Roma, 25 maggio 2005. Available at http://fedemo.it/cat/per-il-medico/rapporti/. Accessed August 9, 2012.
17. Mannucci PM, Roberts HR. Uncertain times for research on hemophilia and allied disorders. J Thromb Haemost 2005; 3: 423.
18. Colvin BT, Astermark J, Fischer K et al. for The inter disciplinary working group. European principles of haemophilia care. Haemophilia 2008; 14, 361-74.
19. Santagostino E, Calizzani G, Hassan HJ et al. Improve AICE: professional accreditation of hemophilia treatment centres in Italy. Blood Transfusion 2008; 6(Suppl. 3): s3 (RE02).
20. Fowler H, Lacey R, Keaney J, Kay-Jones C, Martlew V, Thachil J. Emergency and out of hours care of patients with inherited bleeding disorders. Haemophilia 2012; 18: e126-31.
21. DPR (Decree of the President of Republic) 14 gennaio 1997 Approvazione dell'Atto di indirizzo e coordinamento in materia di requisiti strutturali, tecnologici ed organizzativi minimi per l'esercizio delle attività sanitarie da parte delle strutture pubbliche e private. Available at http://www.salute.gov.it/imgs/C_17_normativa_902_allegato.pdf. Accessed August 8, 2012.